Advertisement
Research Article| Volume 32, ISSUE 4, P302-311, August 15, 1992

GABA agonist-induced changes in motor, oculomotor, and attention measures correlate in schizophrenics with tardive dyskinesia

  • Shawn L. Cassady
    Correspondence
    Addressed reprint requests to Dr. Shawn L. Cassady, Maryland Psychiatric Research Center, P.O. Box 21247, Baltimore, MD 21228.
    Footnotes
    Affiliations
    From the Maryland Psychiatric Research Center, University of Maryland School of Medicine, P.O. Box 21247, Baltimore, MD 21228, USA
    Search for articles by this author
  • Gunvant K. Thaker
    Footnotes
    Affiliations
    From the Maryland Psychiatric Research Center, University of Maryland School of Medicine, P.O. Box 21247, Baltimore, MD 21228, USA
    Search for articles by this author
  • Marianne Moran
    Footnotes
    Affiliations
    From the Maryland Psychiatric Research Center, University of Maryland School of Medicine, P.O. Box 21247, Baltimore, MD 21228, USA
    Search for articles by this author
  • Adrienne Birt
    Footnotes
    Affiliations
    From the Maryland Psychiatric Research Center, University of Maryland School of Medicine, P.O. Box 21247, Baltimore, MD 21228, USA
    Search for articles by this author
  • Carol A. Tamminga
    Footnotes
    Affiliations
    From the Maryland Psychiatric Research Center, University of Maryland School of Medicine, P.O. Box 21247, Baltimore, MD 21228, USA
    Search for articles by this author
  • Author Footnotes
    ∗ The authors would like to thank John and Richard Ellsberry, Juanita Layne-Gedge, and Coleen Heckner for their technical assistance in conducting this study and Ann Summerfelt and Deb Medoff for their statistical assistance.
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Saccadic distractibility, Stroop color-word scores, and serial dyskinesia assessments were obtained on 10 schizophrenic patients with tardive dyskinesia during a pharmacologic challenge with placebo or 7 mg muscimol, a potent, direct-acting GABA agonist. Although no significant difference in the measures was evident between conditions, a significant correlation was found between GABA agonist-induced changes in saccadic distractibility and dyskinesia scores where no correlation existed between these measures on placebo. Improvement in saccadic distractibility was also correlated with reduction in attention performance, as measured by Stroop. These effects are not due to sedation. The correlation between dyskinesia and saccadic distractibility is consistent with a model of parallel motor and oculomotor cortico-striatal-thalamic circuits in humans. This work supports the hypothesis that a dysfunction in GABA-mediated neurotransmission may be the basis for tardive dyskinesia.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Alexander G.E.
        • Crutcher M.R.
        Functional architecture of basal ganglia circuits: neural substrates of parallel processing.
        Trends in Neuroscience. 1990; 13: 266-271
        • Alexander G.E.
        • DeLong M.R.
        • Strick P.L.
        Parallel organization of functionally segregated circuits linking basal ganglia and cortex.
        Ann Rev Neurosci. 1986; 9: 357-381
        • Brehm L.
        • Hjeds H.
        • Krogsgarrd-Larsen P.
        The structure of muscimol, a GABA analogue of restricted conformation.
        Acta Chem Scand. 1972; 26: 1359-1361
        • Casey D.E.
        • Gerlach J.
        • Magelund G.
        • et al.
        Gamma-acetylenic GABA in tardive dyskinesia.
        Arch Gen Psychiatry. 1980; 37: 1376-1379
        • Delong M.R.
        Primate models of movement disorders of basal ganglia origin.
        Trends in Neurosci. 1990; 13: 281-285
        • Fleiss J.L.
        The Design and Analyses of Clinical Experiments.
        Wiley, New York1986
        • Gale K.
        Chronic blockade of dopamine receptors by antischizophrenic drugs enhances GABA binding in substantia nigra.
        Nature. 1980; 283: 569-570
        • Golden C.J.
        Stroop Color and Word Test: A Manual for Clinical and Experimental Uses.
        in: Stoelting, Chicago1978
        • Gunne L.M.
        • Haggstrom J.E.
        • Sjoqust B.
        Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis.
        Nature. 1984; 309: 347-349
        • Hikosaka O.
        • Wurtz R.H.
        Effects on eye movements of a GABA agonist and antagonist injected into monkey superior colliculus.
        Brain Res. 1983; 272: 368-372
        • Hikosaka O.
        • Wurtz R.H.
        Modification of saccadic eye movements by GABA-related substances. I. Effects of muscimol and bicuculline in monkey superior colliculus. II. Effect of muscimol in monkey substantia nigra pars reticulata.
        J Neurophysiol. 1985; 53: 266-308
        • Leigh R.J.
        • Zee D.S.
        The Neurology of Eye Movements.
        ed 2. FA Davis Company, Philadelphia1991
        • Oyanagi K.
        • Takeda H.
        • Takahashi H.
        • et al.
        A quantitative investigation of the substantia nigra in Huntington's disease.
        Ann Neuro. 1989; 26: 13-19
        • Pardo J.V.
        • Pardo P.J.
        • Janer K.W.
        • et al.
        The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm.
        in: Proc Natl Acad Sci USA. 87. 1990: 256-259
        • Scheel-Kruger J.
        Dopamine-GABA interactions: Evidence that GABA transmits, modulates, and mediates dopaminergic functions in the basal ganglia and the limbic system.
        Acta Neurol Scan. 1986; 73: 1-54
        • Schooler N.R.
        • Kane J.M.
        Research diagnosis for tardive dyskinesia.
        Arch Gen Psych. 1982; 39: 486-487
        • Smith R.C.
        • Strizich M.
        • Klass D.
        History of neuroleptic drugs and tardive dyskinesia.
        in: Fann W.E. Smith R.C. Davis J.M. Tardive Dyskinesia: Research and Treatment. SP Medical & Scientific Books, Jamaica, NY1980
        • Tamminga C.A.
        • Crayton J.W.
        • Chase T.N.
        Muscimol: GABA agonist therapy in schizophrenia.
        Am J Psychiatry. 1978; 135: 746-747
        • Tamminga C.
        • Crayton J.
        • Chase T.
        Improvement in tardive dyskinesia after muscimol therapy.
        Arch Gen Psychiatry. 1979; 36: 595-598
        • Tamminga C.A.
        • Thaker G.K.
        • Goldberg S.T.
        Tardive Dyskinesia: GABA Agonist Treatment.
        in: Catecholamines: Neuropharmacology and Central Nervous System—Therapeutic Aspects. 1984: 69-72
        • Tamminga C.A.
        • Thaker G.K.
        GABAmimetic drugs in hyperkinetic involuntary movement disorders and their effects on mental status.
        Drug Dev Res. 1990; 21: 227-233
        • Thaker G.K.
        • Tamminga C.A.
        • Alphs L.
        Brain gamma-aminobutyric acid abnormality in tardive dyskinesia.
        Arch Gen Psychiatry. 1987; 44: 522-529
        • Thaker G.K.
        • Nguyen J.A.
        • Tamminga C.A.
        Increased saccadic distractibility in tardive dyskinesia: Functional evidence for subcortical GABA dysfunction.
        Biol Psychiatry. 1989; 25: 49-59
        • Thaker G.K.
        • Ellsberry R.
        • Moran M.
        • et al.
        Tobacco smoking increases square-wave jerks during pursuit eye movements.
        Biol Psychiatry. 1991; 29: 82-88